B Breast cancer, managing risk of lobular, in hereditary diffuse gastric cancer, 51
|
|
- Griselda Goodman
- 5 years ago
- Views:
Transcription
1 Index Note: Page numbers of article titles are in boldface type. A Adenocarcinoma, gastric. See also Gastric cancer. D2 nodal dissection for Adjuvant therapy, for gastric cancer, impact of D2 dissection on results of, 75 strategies in gastric cancer, chemoradiation, chemotherapy, perioperative chemotherapy, targeted, of gastrointestinal stromal tumor of stomach, Anaplasma lymphoma kinase, in targeted therapy of lung cancer, Angiogenesis inhibitors, clinical trials in advanced gastric cancer, monoclonal antibodies, receptor tyrosine kinase inhibitors, Asia, gastric cancer in. See Eastern experience. B Breast cancer, managing risk of lobular, in hereditary diffuse gastric cancer, 51 C CDH1 genetic testing, for hereditary diffuse gastric cancer, minimum age for, Cell cycle inhibitors, in gastric cancer therapy, 122 Cell cycle regulatory genes, individual genetic alteration as marker in lung cancer, Chemoradiation, adjuvant, for gastric cancer, neoadjuvant, for gastric cancer, Chemotherapy, clinical trials in advanced gastric cancer, preoperative and postoperative for gastric cancer, adjuvant strategies, neoadjuvant strategies, ongoing trials, rationale for, 100 selection of treatment strategy, treatment planning and surgery, 100 Classification, of gastric cancer, role of endoscopy in, 1 3 CLEAN-NET, full-layer resection for gastric cancer with, Clinical trials. See Trials. D D1 nodal dissection, trials in gastric cancer, D2 nodal dissection, for gastric cancer, impact on results of adjuvant therapy, Surg Oncol Clin N Am 21 (2012) doi: /s (11) surgonc.theclinics.com /12/$ see front matter ª 2012 Elsevier Inc. All rights reserved.
2 178 Index D2 nodal (continued) standard and modified, for gastric adenocarcinoma, definition of nodal stations and, future of, 69 indications for modifications of, learning curve and surgical quality concerns, Maruyama index and, technique, trials in gastric cancer, Diffuse gastric cancer, hereditary. See Hereditary diffuse gastric cancer. E E-cadherin gene (CDH1), in hereditary diffuse gastric cancer, 35 East-West differences, in gastric cancer diagnosis and staging, in gastric cancer surgery, overall survival in clinical trials, stage-specific results of resected cancers, Eastern experience, with gastric cancer, compared with Western, overall survival in clinical trials, stage-specific results of resected cancers, guidelines for standard treatment, 71 impact of D2 dissection on adjuvant therapy results, 75 splenectomy, 73, 75 stage migration, 73 Endoscopic mucosal resection (EMR), basic principles, 130 choosing appropriate lesions for, CLEAN-NET, development of, 130 evaluation of lateral margins of tumor during, 132 for in situ and T-1 gastric cancer, trials of, full-layer resection, techniques, Endoscopic submucosal dissection (ESD), basic principles, 130 choosing appropriate lesions for, CLEAN-NET, development of, 130 evaluation of lateral margins of tumor during, 132 for in situ and T-1 gastric cancer, trials of, full-layer resection, techniques, Endoscopic ultrasound (EUS), in classification and diagnosis of gastric cancer, 9 12 comparison with other imaging modalities, 10 for early gastric cancer, in metastatic disease, N stage, 10 T stage, 9 10 Endoscopy, endoscopic mucosal resection, endoscopic submucosal dissection (ESD),
3 Index 179 in gastric cancer diagnosis and staging, 1 19 classification and staging, 1 3 comparison with other imaging modalities, 10 endoscopic detection, 3 6 endoscopic ultrasound (EUS), 9 for early gastric cancer, image-enhancing technologies, 6 9 linitis plastica, metastatic disease, N stage, 10 screening, T stage, 9 10 screening, in hereditary diffuse gastric cancer, Epidemiology, of hereditary diffuse gastric cancer, 37 Epidermal growth factor (EGF) receptor, in targeted therapy of lung cancer, phase I and II clinical trials of targeted gastric cancer therapy, Excision repair cross complementing 1, individual genetic alteration as marker in lung cancer, 163 F Familial gastric cancer. See Hereditary diffuse gastric cancer. Fertility issues, with total gastrectomy for hereditary diffuse gastric cancer, 51 Full-layer resection, of gastric cancer, endoscopic and laparoscopic, 135 with CLEAN-NET, G Gastrectomy, total, D2 nodal dissection for distal and, in hereditary diffuse gastric cancer, management in teenage years, mortality and morbidity risks, 49 prognosis and follow-up after, 50 staging and technical aspects, routine, versus subtotal gastrectomy, results of trials, Gastric cancer, chemotherapy, preoperative and postoperative, adjuvant strategies, neoadjuvant strategies, ongoing trials, rationale for, 100 selection of treatment strategy, treatment planning and surgery, 100 Eastern experience with, guidelines for standard treatment, 71 impact of D2 dissection on adjuvant therapy results, 75 overall survival in clinical trials in East and West, splenectomy, 73, 75 stage migration, 73 stage-specific results of resected cancers in East and West, endoscopic diagnosis and staging, 1 19
4 180 Index Gastric (continued) classification and staging, 1 3 comparison with other imaging modalities, 10 endoscopic detection, 3 6 endoscopic ultrasound (EUS), 9 EUS for early gastric cancer, image-enhancing technologies, 6 9 linitis plastica, metastatic disease, N stage, 10 screening, T stage, 9 10 endoscopic mucosal resection (EMR) and submucosal dissection (ESD), basic principles, 130 choosing appropriate lesions for, CLEAN-NET, development of, 130 EMR techniques-133, 132 ESD techniques-133, evaluation of lateral margins of tumor during, 132 full-layer resection, gastrointestinal stromal tumors (GIST) of the stomach, adjuvant targeted therapy, laparoscopic and open resection techniques, molecular analysis, neoadjuvant targeted therapy, pathology, 23 preoperative imaging, 22 resistance to targeted therapy, staging, hereditary diffuse, CDH1 genetic testing and mutation searching, consensus guidelines, 36 epidemiology, risk assessment, and penetrance, 37 genetics of, minimum age for genetic testing and intervention, models of, pathology of, surveillance and screening gastroscopy in, total gastrectomy in, laparoscopic resection of, Western experience with, evolving experience with minimally invasive surgery for, future applications, 154 indications and contraindications, learning curve, rationale for diagnostic laparoscopy and cytology, 142 results and outcomes, phase I and II clinical trials, cell cycle inhibitors, 122 chemotherapy in advanced cancers, histone deacetylase inhibitors, 121
5 Index 181 inhibitors of angiogenesis, mammalian target of rapamycin (mtor) and its inhibition, 120 mesenchymal-epithelial transition factor, 121 others, 122 strategies targeting epidermal growth factor receptor, standard D2 and modified nodal dissection for adenocarcinoma, definition of nodal stations and, future of, 69 indications for modifications of, learning curve and surgical quality concerns, Maruyama index and, technique, surgery, implications of trials, East-West differences in diagnosis and staging, extended para-aortic node dissection, extent of lymphadenectomy, D1 vs. D2, extent of resection, total vs. subtotal gastrectomy, future trails, planning a low Maruyama index operation, role of endoscopic mucosal/submucosal resection, Gastrointestinal stromal tumors (GIST), of the stomach, adjuvant targeted therapy, laparoscopic and open resection techniques, molecular analysis, neoadjuvant targeted therapy, pathology, 23 preoperative imaging, 22 resistance to targeted therapy, staging, Gastroscopy, screening with, in hereditary diffuse gastric cancer, Gene arrays, individual genetic alteration as marker in lung cancer, Genetic alterations, individual molecular markers in lung cancer, cell cycle regulatory genes, excision repair cross-complementing 1, 163 gene arrays, k-ras, p53, 162 Genetics, of hereditary diffuse gastric cancer, GIST. See Gastrointestinal stromal tumor. H Helicobacter pylori eradication, in hereditary diffuse gastric cancer, 51 Her2 (erb2), phase I and II clinical trials of targeted gastric cancer therapy, 120 Hereditary diffuse gastric cancer, CDH1 genetic testing and mutation searching, consensus guidelines, 36 epidemiology, risk assessment, and penetrance, 37 genetics of, minimum age for genetic testing and intervention, models of, 43 45
6 182 Index Hereditary (continued ) pathology of, surveillance and screening gastroscopy in, total gastrectomy in, Histone deacetylase inhibitors, in gastric cancer therapy, 121 I Imaging, preoperative, of gastrointestinal stromal tumor of stomach, 22 Imatinib, resistance to, in targeted therapy for gastrointestinal stromal tumors, K k-ras, individual genetic alteration as marker in lung cancer, L Laparoscopic resection, of gastric carcinoma, Western experience with, evolving experience with minimally invasive surgery for, future applications, 154 indications and contraindications, learning curve, rationale for diagnostic laparoscopy and cytology, 142 results and outcomes, of gastrointestinal stromal tumor of stomach, Learning curve, for D2 nodal dissection, for laparoscopic resection of gastric carcinoma, Linitis plastica, endoscopic appearance of, Lobular breast cancer, managing risk of, in hereditary diffuse gastric cancer, 51 Lung cancer, molecular markers in, individual genetic alterations, cell cycle regulatory genes, excision repair cross-complementing 1, 163 gene arrays, k-ras, p53, 162 micrornas, personalized treatment, current trials of, proteomics, 167 tyrosine kinases and targeted therapies, anaplasmic lymphoma kinase, epidermal growth factor receptor, vascular endothelial growth factor receptor, 166 Lymphadenectomy. See also D2 nodal dissection. extended para-aortic node dissection, extent of, trials of D1 vs. D2, M Mammalian target of rapamycin (mtor), phase I and II clinical trials of targeted gastric cancer therapy, 120 Maruyama index (MI), for D2 nodal dissection, planning a low MI operation, Mesenchymal-epithelial transition factor, in gastric cancer therapy, 121 Metastatic disease, in gastric cancer, role of endoscopy, 10 11
7 Index 183 MicroRNAs, in lung cancer prognostication, Minimally invasive techniques, endoscopic diagnosis and staging of gastric cancer, 1 19 endoscopic mucosal resection (EMR) and submucosal dissection (ESD), laparoscopic resection of gastric cancer, Molecular analysis, of gastrointestinal stromal tumor of stomach, 22 Molecular markers, in lung cancer, individual genetic alterations, cell cycle regulatory genes, excision repair cross-complementing 1, 163 gene arrays, k-ras, p53, 162 micrornas, personalized treatment, current trials of, proteomics, 167 tyrosine kinases and targeted therapies, anaplasmic lymphoma kinase, epidermal growth factor receptor, vascular endothelial growth factor receptor, 166 Monoclonal antibodies, clinical trials in advanced gastric cancer, Mutation searching, in testing for hereditary diffuse gastric cancer, N Neoadjuvant therapy, strategies for gastric cancer, targeted, of gastrointestinal stromal tumor of stomach, Nodal dissection. See D2 nodal dissection. Nodal stations, around the stomach, definition of, O Open resection, of gastrointestinal stromal tumor of stomach, P p53, individual genetic alteration as marker in lung cancer, 162 Para-aortic node dissection, extended, in gastric cancer, Pathology, of hereditary diffuse gastric cancer, Penetrance, of hereditary diffuse gastric cancer, 37 Prophylactic gastrectomy, in hereditary diffuse gastric cancer, Proteomics, in lung cancer prognostication, 167 Q Quality control, surgical, for D2 nodal dissection, R Radiation therapy. See Chemoradiation. Resection, laparoscopic and open, of gastrointestinal stromal tumor of stomach, Resistance, to targeted therapy for gastrointestinal stromal tumors, Risk assessment, in hereditary diffuse gastric cancer, 37
8 184 Index S Screening, for gastric cancer, role of endoscopy, with gastroscopy in hereditary diffuse gastric cancer, Splenectomy, in gastric cancer, 73, 75 Stage migration, in gastric cancer, source of, Staging, of gastric cancer, East-West differences in, of gastric cancer, role of endoscopy in, 1 3 of gastrointestinal stromal tumor. of stomach, Surgery, endoscopic. See Endoscopy and specific procedures. for gastric cancer, implications of clinical trials, East-West differences in diagnosis and staging, extended para-aortic node dissection, extent of lymphadenectomy, D1 vs. D2, extent of resection, total vs. subtotal gastrectomy, future trails, planning a low Maruyama index operation, role of endoscopic mucosal/submucosal resection, laparoscopic. See Laparoscopic resection. standard D2 and modified nodal dissection for gastric adenocarcinoma, definition of nodal stations and, future of, 69 indications for modifications of, learning curve and surgical quality concerns, Maruyama index and, technique, Surveillance, in hereditary diffuse gastric cancer, Survival, overall, in gastric cancer clinical trials in the East and West, T Targeted therapy, of gastric cancer, phase I and II clinical trials of, cell cycle inhibitors, 122 epidermal growth factor receptor, histone deacetylase inhibitors, 121 inhibitors of angiogenesis, mammalian target of rapamycin (mtor) and its inhibition, 120 mesenchymal-epithelial transition factor, 121 others, 122 of gastrointestinal stromal tumor of stomach, adjuvant, neoadjuvant, resistance to, tyrosine kinases in lung cancer, anaplasmic lymphoma kinase, epidermal growth factor receptor, vascular endothelial growth factor receptor, 166 Trials, ongoing, in chemotherapy for gastric cancer, phase I and II clinical, for gastric cancer, cell cycle inhibitors, 122 chemotherapy in advanced cancers, histone deacetylase inhibitors, 121
9 Index 185 inhibitors of angiogenesis, mammalian target of rapamycin (mtor) and its inhibition, 120 mesenchymal-epithelial transition factor, 121 others, 122 strategies targeting epidermal growth factor receptor, surgical for gastric cancer, implications of, East-West differences in diagnosis and staging, extended para-aortic node dissection, extent of lymphadenectomy, D1 vs. D2, extent of resection, total vs. subtotal gastrectomy, future trails, planning a low Maruyama index operation, role of endoscopic mucosal/submucosal resection, Tyrosine kinase inhibitors, clinical trials in advanced gastric cancer, resistance to, in targeted therapy for gastrointestinal stromal tumors, Tyrosine kinases, and targeted therapies in lung cancer, anaplasmic lymphoma kinase, epidermal growth factor receptor, vascular endothelial growth factor receptor, 166 U Ultrasound, endoscopic. See Endoscopic ultrasound. V Vascular endothelial growth factor (VEGF) receptor, in targeted therapy of lung cancer, 166 W Western experience. See also East-West differences., with laparoscopic resection of gastric carcinoma, evolving experience with minimally invasive surgery for, future applications, 154 indications and contraindications, learning curve, rationale for diagnostic laparoscopy and cytology, 142 results and outcomes,
Index. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal drainage, after hepatic resection, 159 160 Ablation, radiofrequency, for hepatocellular carcinoma, 160 161 Adenocarcinoma, pancreatic.
More informationIndex. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
More informationسرطان المعدة. Gastric Cancer حمود حامد
سرطان المعدة Gastric Cancer ا أ لستاذ الدك تور حمود حامد عميد كلية الطب البشري بجامعة دمشق Epidemiology second leading cause of cancer death and fourth most common cancer worldwide Overall declining Histologic
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adenocarcinoma, pancreatic ductal, laparoscopic distal pancreatectomy for, 61 Adrenal cortical carcinoma, laparoscopic adrenalectomy for, 114
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abdominoperineal excision, of rectal cancer, 93 111 current controversies in, 106 109 extent of perineal dissection and removal of pelvic floor,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Adaptive therapy, for locally advanced gastroesophageal cancers, 447 Adenocarcinoma, emerging novel therapeutic agents for gastroesophageal
More informationIndex. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 14 (2005) 433 439 Index Note: Page numbers of article titles are in boldface type. A Abdominosacral resection, of recurrent rectal cancer, 202 215 Ablative techniques, image-guided,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal surgery prior as factor in laparoscopic colorectal surgery, 554 555 Abscess(es) CRC presenting as, 539 540 Adenocarcinoma of
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Ablative therapy, nonsurgical, for pulmonary metastases of soft tissue sarcoma, 279 280 Adipocytic tumors, atypical lipomatous tumor vs. well-differentiated
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, for early-stage triple-negative breast cancer, 740 742 in older early-stage breast cancer patients, 790 795 anti-her2-directed
More informationThe Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum
The Royal Marsden Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum The Royal Marsden William Allum Conflict of Interest None Any surgeon can cure Surgeon - dependent
More informationMichael A. Choti, MD, FACS Department of Surgery Johns Hopkins Medicine, Baltimore, MD
Michael A. Choti, MD, FACS Department of Surgery Johns Hopkins Medicine, Baltimore, MD Surgical Therapy of Gastric Cancer CLINICAL QUESTIONS 1. How much of the stomach should be removed? 2. How many lymph
More informationLek. Agnieszka Słowik Oddział Kliniczny Onkologii Collegium Medicum UJ
Lek. Agnieszka Słowik Oddział Kliniczny Onkologii Collegium Medicum UJ 1. Introduction 2. Epidemiology 3. Gastric cancer and pancreatic cancer a. Risk factors b. Symptoms c. Location d. Diagnosis e. Histopathology
More informationGastric Cancer: Surgery and Regional Therapy. Epidemiology. Risk factors
Gastric Cancer: Surgery and Regional Therapy Timothy J. Kennedy, MD Montefiore Medical Center Assistant Professor of Surgery Upper Gastrointestinal and Pancreas Surgery December 15, 2012 1 Epidemiology
More informationGASTRIC CANCER. Joyce Au SUNY Downstate Grand Rounds July 11, 2013
GASTRIC CANCER Joyce Au SUNY Downstate Grand Rounds July 11, 2013 xxm with gastric adenocarcinoma on biopsy of antral lesion on EGD at outside hospital PMH: residual schizophrenia, HTN PSH: exploratory
More informationCase Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.
Case Scenario 1 July 10, 2010 A 67-year-old male with squamous cell carcinoma of the mid thoracic esophagus presents for surgical resection. The patient has completed preoperative chemoradiation. This
More informationThe Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum Consultant Surgeon
The Royal Marsden Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum Consultant Surgeon Any surgeon can cure Surgeon - dependent No surgeon can cure EMR D2 GASTRECTOMY
More informationB Barrett neoplasia, early, endoscopic mucosal resection of, in Europe, 297
Note: Page numbers of article titles are in boldface type. A Achalasia, treatment of, history of, 258 259 Achalasia myotomy, 270 Adenocarcinomas, endoscopic management of, in Asia, 289 290 B Barrett neoplasia,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation. See specific types, e.g., Thermal ablation Achalasia, 53 75 described, 53 features of, 53 management of past options, 54 POEM
More informationEsophageal cancer: Biology, natural history, staging and therapeutic options
EGEUS 2nd Meeting Esophageal cancer: Biology, natural history, staging and therapeutic options Michael Bau Mortensen MD, Ph.D. Associate Professor of Surgery Centre for Surgical Ultrasound, Upper GI Section,
More informationNational Oesophago-Gastric Cancer Audit New Patient Registration sheet Patients with Oesophageal High Grade Glandular Dysplasia
National Oesophago-Gastric Cancer Audit New Patient Registration sheet Patients with Oesophageal High Grade Glandular Dysplasia Patient Details Surname: NHS number: Forename: Postcode: Sex: Male Female
More informationChapter 2: Initial treatment for endometrial cancer (including histologic variant type)
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?
More informationGastric Cancer: Etiologic Factors. H. Pylori diet (salt, nitrates) lifestyle (smoking, obesity) familial (~10% in West) diet hereditary
Issue #1: Premalignant Lesions Gastric Cancer: Etiologic Factors H. Pylori diet (salt, nitrates) lifestyle (smoking, obesity) familial (~10% in West) diet hereditary HNPCC DGC Lauren Classification of
More informationIndex. Azygous vein division of, thoracoscopic division of, 150
A Adenocarcinoma of esophagus acute and chronic inflammation, 6 7 gastroesophageal reflux disease, 5 6 genetic factors, 4 5 Helicobacter pylori infection, 6 incidence, 4 obesity, 6 gastric cancer, 61 65
More informationGastric Cancer in a Young Postpartum Female. Kings County Hospital Center SUNY Downstate Case Conference May 24, 2012
Gastric Cancer in a Young Postpartum Female Kings County Hospital Center SUNY Downstate Case Conference May 24, 2012 Case HPI: 31 yo F, G5P3, 3 weeks s/p C-section, with gastric outlet obstruction. Pt
More informationConventional Gastrectomy for Gastric Cancer. Franklin Wright UCHSC Department of Surgery Grand Rounds January 14, 2008
Conventional Gastrectomy for Gastric Cancer Franklin Wright UCHSC Department of Surgery Grand Rounds January 14, 2008 Overview Gastric Adenocarcinoma Conventional vs Radical Lymphadenectomy Non-randomized
More informationOncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R
Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R 2 0 1 2 Objectives Discuss Diagnostic and staging strategies in oncology Know
More informationCase Presentation: GIST
Case Presentation: GIST 9 th Annual Clinical Cancer Update Conference Squaw Creek, North Lake Tahoe January 2010 Anne Espinoza, M.D. Hematology/Oncology Fellow University of California, San Francisco Initial
More informationEsophageal Cancer. Wesley A. Papenfuss MD FACS Surgical Oncology Aurora Cancer Care. David Demos MD Thoracic Surgery Aurora Cancer Care
Esophageal Cancer Wesley A. Papenfuss MD FACS Surgical Oncology Aurora Cancer Care David Demos MD Thoracic Surgery Aurora Cancer Care No Disclosures Learning Objectives Review the classification scheme
More informationCOLLECTING CANCER DATA: STOMACH AND ESOPHAGUS
COLLECTING CANCER DATA: STOMACH AND ESOPHAGUS 2017 2018 NAACCR WEBINAR SERIES Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching
More informationSignificance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories
Original Article Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories Wu Song, Yulong He, Shaochuan Wang, Weiling
More informationAdvancing Diagnosis and Treatment for Gastric Cancer
Advancing Diagnosis and Treatment for Gastric Cancer The Gastric Cancer Care Program of NewYork-Presbyterian/Columbia University Medical Center provides a comprehensive strategy of early detection, multidisciplinary
More informationADVANCES IN SURGERY INDEX. who should have or not have axillary node dissection with, 1 18
Advances in Surgery 46 (2012) 297 301 ADVANCES IN SURGERY A Abdominal aortic aneurysms, medical screening for, 102 multivariate risk score, 106 repair of, readmission rates following, 166 167 ruptured,
More informationStomach. R.B. Kolachalam, MD
Stomach R.B. Kolachalam, MD Relevent Anatomy 1.four regions: Cardia, Fundus, Body, and the Pylorus 2. fixed in two locations- at the GEJ and the duodenum Gastric Anatomy body of the stomach: site of mechanical
More informationGastric adenocarcinoma Bern
Gastric adenocarcinoma 18.10.2017 Bern Epidemiology Worldwide 5th cancer with 950 000 new cases per year, 161 000 in Europe, 683 in Switzerland 3 rd cause of mortality worldwide, 485 cases/year in Switzerland
More informationCase Report Intramucosal Signet Ring Cell Gastric Cancer Diagnosed 15 Months after the Initial Endoscopic Examination
Hindawi Publishing Corporation Case Reports in Medicine Volume 2015, Article ID 479625, 5 pages http://dx.doi.org/10.1155/2015/479625 Case Report Intramucosal Signet Ring Cell Gastric Cancer Diagnosed
More informationIndex. Note: Page numbers of article titles are in boldface type. A Age as factor in melanoma, Anorectal melanoma RT for, 1035
Index Note: Page numbers of article titles are in boldface type. A Age as factor in melanoma, 947 948 Anorectal melanoma RT for, 1035 B Bacille Calmette-Guerin (BCG) in melanoma, 1008 BCG. See Bacille
More informationControversies in management of squamous esophageal cancer
2015.06.12 12.47.48 Page 4(1) IS-1 Controversies in management of squamous esophageal cancer C S Pramesh Thoracic Surgery, Department of Surgical Oncology, Tata Memorial Centre, India In Asia, squamous
More informationThe following slides are provided as presented by the author during the live educa7onal ac7vity and are intended for reference purposes only.
The following slides are provided as presented by the author during the live educa7onal ac7vity and are intended for reference purposes only. If you have any ques7ons, please contact Imedex via email at:
More informationApproaches to Surgical Treatment of Gastric Cancer. Byrne Lee, MD FACS Chief, Mixed Tumor Surgery Service
Approaches to Surgical Treatment of Gastric Cancer Byrne Lee, MD FACS Chief, Mixed Tumor Surgery Service Disclosures I do not have anything to disclose Outline Background Diagnosis Histology Staging Surgery
More informationUniversity Mainz. Early Gastric Cancer. Ralf Kiesslich. Johannes Gutenberg University Mainz, Germany. Early Gastric Cancer 15.6.
Ralf Kiesslich Johannes Gutenberg University Mainz, Germany DIAGNOSIS Unmask lesions - Chromoendoscopy -NBI Red flag technology - Autofluorescence Surface and detail analysis - Magnifying endoscopy - High
More informationPrinted by Hadi Ranjkeshzadeh on 11/12/2010 4:40:23 PM. For personal use only. Not approved for distribution. Copyright 2010 National Comprehensive
Discussion Categories of Evidence and Consensus Category 1: The recommendation is based on high-level evidence (e.g. randomized controlled trials) and there is uniform consensus. Category 2A: The recommendation
More informationSurgical Treatment of Gastric Cancer
SMGr up Surgical Treatment of Gastric Cancer Igor Correia de Farias 1 *, Maria Luiza Leite de Medeiros 2, Wilson Luiz da Costa Júnior 1, Heber Salvador de Castro Ribeiro 1, Alessandro Landskron Diniz 1,
More informationIt is a malignancy originating from breast tissue
59 Breast cancer 1 It is a malignancy originating from breast tissue including both early stages which are potentially curable, and metastatic breast cancer (MBC) which is usually incurable. Most breast
More informationGastrointestinal Tract Cancer
Gastrointestinal Tract Cancer Tumors of the Stomach Gastric adenocarcinoma Incidence and Epidemiology Incidence mortality rates USA High incidence: Japan, China, Chile, Ireland risk lower socioeconomic
More informationTUMORS OF THE STOMACH AND SMALL BOWEL
gastrointestinal tract and abdomen TUMORS OF THE STOMACH AND SMALL BOWEL L. Mark Knab, MD, David J. Bentrem, MD, FACS, and Jeffrey D. Wayne, MD, FACS * Gastric Adenocarcinoma The incidence of gastric carcinoma
More informationThe detection rate of early gastric cancer has been increasing owing to advances in
Focused Issue of This Month Sung Hoon Noh, MD, ph.d Department of Surgery, Yonsei University College of Medicine E - mail : sunghoonn@yuhs.ac J Korean Med Assoc 2010; 53(4): 306-310 Abstract The detection
More informationPrinciples of diagnosis, work-up and therapy The Gastroenterologist s role
Principles of diagnosis, work-up and therapy The Gastroenterologist s role Dr. Christos G. Toumpanakis MD PhD FRCP Consultant in Gastroenterology/Neuroendocrine Tumours Hon. Senior Lecturer University
More informationSubepithelial Lesions of the Gut: When Should I Worry?
Subepithelial Lesions of the Gut: When Should I Worry? President, ASGE Chairman, GI & Hepatology Scottsdale, AZ Faigel.douglas@mayo.edu Case 55 yo male with reflux EGD for Barrett s Screening SET, mucosal
More informationRADIOFREQUENCY ABLATION
RADIOFREQUENCY ABLATION ELIZABETH DAVID M D FRCPC VASCULAR A ND INTERVENTIONAL RADIOLOGIST SUNNYBROOK HEALTH SCIENCES CENTRE GIST GASTROINTESTINAL STROMAL TUMORS Stromal or mesenchymal neoplasms affecting
More informationBy Prof. Mohamed Khaled Zaky, MB,BCh; MSc; MD; FRCSI (Gen. Surg.) Professor of Surgery, Taibah Univ.
By Prof. Mohamed Khaled Zaky, MB,BCh; MSc; MD; FRCSI (Gen. Surg.) Professor of Surgery, Taibah Univ. Objectives Types Incidence Risk factors (& prevention) Pathology: Gross, microscopic, spread, staging,
More informationis time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the
My name is Barry Feig. I am a Professor of Surgical Oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas. I am going to talk to you today about the role for surgery in the treatment
More informationHereditary Gastric Cancer
Hereditary Gastric Cancer Dr Bastiaan de Boer Consultant Pathologist Department of Anatomical Pathology PathWest Laboratory Medicine, QE II Medical Centre Clinical Associate Professor School of Pathology
More informationCase Scenario year-old white male presented to personal physician with dyspepsia with reflux.
Case Scenario 1 57-year-old white male presented to personal physician with dyspepsia with reflux. 7/12 EGD: In the gastroesophageal junction we found an exophytic tumor. The tumor occupies approximately
More informationA Proposed Strategy for Treatment of Superficial Carcinoma. in the Thoracic Esophagus Based on an Analysis. of Lymph Node Metastasis
Kitakanto Med J 2002 ; 52 : 189-193 189 A Proposed Strategy for Treatment of Superficial Carcinoma in the Thoracic Esophagus Based on an Analysis of Lymph Node Metastasis Susumu Kawate,' Susumu Ohwada,'
More informationSurgical Problems in Proximal GI Cancer Management Cardia Tumours Question #1: What are cardia tumours?
Surgical Problems in Proximal GI Cancer Management Cardia Tumours Question #1: What are cardia tumours? Question #2: How are cardia tumours managed? Michael F. Humer December 3, 2005 Vancouver, BC Case
More informationManagement of Neck Metastasis from Unknown Primary
Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough
More informationA study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric cancer.
Biomedical Research 2018; 29 (2): 365-370 ISSN 0970-938X www.biomedres.info A study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric
More informationAdvances in gastric cancer: How to approach localised disease?
Advances in gastric cancer: How to approach localised disease? Andrés Cervantes Professor of Medicine Classical approach to localised gastric cancer Surgical resection Pathology assessment and estimation
More informationImaging in gastric cancer
Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.
More informationGastric and Colon Cancer. Dr. Andres Wiernik 2017
Gastric and Colon Cancer Dr. Andres Wiernik 2017 GASTRIC CANCER Gastric Cancer Classification Epidemiology General principles of Management 25% GE Junction Gastric Cancer 75% Gastric Cancer Epidemiology
More informationMedicina Personalizada de Precisión en el Abordaje del Cáncer Gástrico. Dra Desamparados Roda Pérez Hospital Clínico de Valencia Incliva, CIBERONC
Medicina Personalizada de Precisión en el Abordaje del Cáncer Gástrico Dra Desamparados Roda Pérez Hospital Clínico de Valencia Incliva, CIBERONC Gastric cancer Epidemiology Gastric cancer is an important
More informationA superficial radiotherapy B single pass curettage C excision with 2 mm margins D excision with 5 mm margins E Mohs micrographic surgery.
1- A 63-year-old woman presents with a non-healing lesion on her right temple that has been present for over two years. On examination there is a 6 mm well defined lesion with central ulceration, telangiectasia
More informationBreast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015
Breast Surgery When Less is More and More is Less E MacIntosh, MD June 6, 2015 Presenter Disclosure Faculty: E. MacIntosh Relationships with commercial interests: None Mitigating Potential Bias Not applicable
More informationNavigators Lead the Way
RN Navigators Their Role in patients with Cancers of the GI tract Navigators Lead the Way Nurse Navigator Defined Nurse Navigator A clinically trained individual responsible for the identification and
More informationNICE guideline Published: 24 January 2018 nice.org.uk/guidance/ng83
Oesophago-gastric cancer: assessment and management in adults NICE guideline Published: 24 January 18 nice.org.uk/guidance/ng83 NICE 18. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationSubtotal gastrectomy for gastric cancer
Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v20.i38.13667 World J Gastroenterol 2014 October 14; 20(38): 13667-13680 ISSN 1007-9327
More informationRadiation Oncology MOC Study Guide
Radiation Oncology MOC Study Guide The following study guide is intended to give a general overview of the type of material that will be covered on the Radiation Oncology Maintenance of Certification (MOC)
More informationAbstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology:
Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 A 74 year old male with a history of GERD presents complaining of dysphagia. An esophagogastroduodenoscopy
More informationUpdate on Hereditary Gastric Cancer. Dr. Savtaj Brar MD MSc Surgical Oncologist Assistant Professor of Surgery
Update on Hereditary Gastric Cancer Dr. Savtaj Brar MD MSc Surgical Oncologist Assistant Professor of Surgery Disclosures None Outline 1. Discuss new consensus guidelines on hereditary diffuse gastric
More informationGastric Cancer Staging AJCC eighth edition. Duncan McLeod Westmead Hospital, NSW
Gastric Cancer Staging AJCC eighth edition Duncan McLeod Westmead Hospital, NSW Summary of changes New clinical stage prognostic groups, ctnm Postneoadjuvant therapy pathologic stage groupings, yptnm -
More informationPresent Status and Perspectives of Colorectal Cancer in Asia: Colorectal Cancer Working Group Report in 30th Asia-Pacific Cancer Conference
Present Status and Perspectives of Colorectal Cancer in Asia: Colorectal Cancer Working Group Report in 30th Asia-Pacific Cancer Conference Jpn J Clin Oncol 2010;40(Supplement 1)i38 i43 doi:10.1093/jjco/hyq125
More informationCLINICAL EFFECTIVENESS
Re-audit of gastrointestinal tract specimens with respect to compliance with RCPath guidelines Dr Manisha Ram Dr Moina Kadri Background epidemiology and aetiology Over the past 20 years there has been
More informationRare GI Malignancies
Rare GI Malignancies Jordan Karlitz, MD Associate Professor of Medicine, Division of Gastroenterology Director, Hereditary GI Cancer and Genetics Program Tulane University School of Medicine Outline Gastrointestinal
More informationAre we making progress? Marked reduction in operative morbidity and mortality
Are we making progress? Surgical Progress Marked reduction in operative morbidity and mortality Introduction of Minimal-Access approaches for complex esophageal cancer resections Significantly better functional
More informationMichael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center
Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center 50 yo healthy postmenopausal female with BMI = 35 with screening PAP smear = AGUS. What is the next step? (1) Colposcopy
More informationOesophagogastric Cancer The Patient s Pathway
National helpline: 0121 704 9860 V1 Oesophagogastric Cancer The Patient s Pathway {Based on The St Thomas Hospital Pathway} Registered Charity No. 1062461 Contents Introduction 3-5 Curative pathway 5-7
More informationHow many lymph nodes are enough? defining the extent of lymph node dissection in stage I III gastric cancer using the National Cancer Database
Original Article How many lymph nodes are enough? defining the extent of lymph node dissection in stage I III gastric cancer using the National Cancer Database Karna Sura, Hong Ye, Charles C. Vu, John
More informationImages In Gastroenterology
Images In Gastroenterology Thong-Ngam D, et al. THAI J GASTROENTEROL 2005 Vol. 6 No. 2 May - Aug. 2005 105 Imaging of Gastrointestinal Stromal Tumors Pornpim Fuangtharnthip, M.D. Narumol Hargroove, M.D.
More informationResearch Article Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy
International Surgical Oncology Volume 2012, Article ID 307670, 7 pages doi:10.1155/2012/307670 Research Article Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy
More informationColonic Polyp. Najmeh Aletaha. MD
Colonic Polyp Najmeh Aletaha. MD 1 Polyps & classification 2 Colorectal cancer risk factors 3 Pathogenesis 4 Surveillance polyp of the colon refers to a protuberance into the lumen above the surrounding
More informationOutcome after emergency surgery in patients with a free perforation caused by gastric cancer
experimental and therapeutic medicine 1: 199-203, 2010 199 Outcome after emergency surgery in patients with a free perforation caused by gastric cancer Hironori Tsujimoto 1, Shuichi Hiraki 1, Naoko Sakamoto
More informationCASE DISCUSSION ON GASTRIC CANCER BASED ON ESMO GUIDELINES
ESMO Preceptorship GI Tumours Singapore 20-22 nd October CASE DISCUSSION ON GASTRIC CANCER BASED ON ESMO GUIDELINES Professor. J-Y. Douillard MD PhD ESMO Chief Medical Officer CLINICAL PRACTICE GUIDELINES
More informationTotally laparoscopic distal gastrectomy reconstructed by Rouxen-Y with D2 lymphadenectomy and needle catheter jejunostomy for gastric cancer
Masters of Gastrointestinal Surgery Totally laparoscopic distal gastrectomy reconstructed by Rouxen-Y with D2 lymphadenectomy and needle catheter jejunostomy for gastric cancer Xin Ye, Jian-Chun Yu, Wei-Ming
More informationComparison of lymph node number and prognosis in gastric cancer patients with perigastric lymph nodes retrieved by surgeons and pathologists
Original Article Comparison of lymph node number and prognosis in gastric cancer patients with perigastric lymph nodes retrieved by surgeons and pathologists Lixin Jiang, Zengwu Yao, Yifei Zhang, Jinchen
More informationReduced Lymph Node Harvest after Neoadjuvant Chemotherapy in Gastric Cancer
The Journal of International Medical Research 2011; 39: 2086 2095 Reduced Lymph Node Harvest after Neoadjuvant Chemotherapy in Gastric Cancer Z-M WU 1, R-Y TENG 2, J-G SHEN 2, S-D XIE 2, C-Y XU 2,3 AND
More informationSAMPLE. Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to Reference Code: GDHC0004RCCDVR Publication Date: March 2012
Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to Reference Code: GDHC0004RCCDVR Publication Date: March 2012 The Renal Cell Carcinoma (RCC) Disease Therapeutics Market GlobalData s analysis suggests
More informationGastric (Stomach) Cancer
Gastric (Stomach) Cancer Gastric cancer is a disease in which malignant (cancer) cells form in the lining of the stomach. The stomach is a J-shaped organ in the upper abdomen. It is part of the digestive
More informationBreast Surgery: Yesterday, Today and Tomorrow
Breast Surgery: Yesterday, Today and Tomorrow Baptist Hospital Gladys L. Giron, MD, FACS October 11,2014 Homestead Hospital Baptist Children s Hospital Doctors Hospital Baptist Cardiac & Vascular Institute
More informationOPEN ACCESS TEXTBOOK OF GENERAL SURGERY
OPEN ACCESS TEXTBOOK OF GENERAL SURGERY GASTRIC CARCINOMA E PANIERI G CHINNERY B ROBERTSON INTRODUCTION Gastric neoplasms are common, and because they often present late, they arefrequently incurable.
More informationANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:
1 ANNEX 1 OBJECTIVES At the completion of the training period, the fellow should be able to: 1. Breast Surgery Evaluate and manage common benign and malignant breast conditions. Assess the indications
More informationGASTRIC CANCER DR AMIR ASHRAFI
GASTRIC CANCER DR AMIR ASHRAFI Epidemiology Aetiologic factors Classification Clinical features Investigations Staging Treatment EPIDEMIOLOGY AND FACTS ü Worldwide, gastric cancer is the fourth most common
More informationTechnical and Endoscopic Factors in. in CDH1 Mutation Carriers
Technical and Endoscopic Factors in Gastric Cancer Surveillance in CDH Mutation Carriers Carol A. Burke,3,5, Michael Cruise 2,5, Lisa LaGuardia 3,5, Margaret O Malley 3,5, Matthew Kalady 3,5, James Church
More informationGuidelines for Extended Lymphadenectomy in Gastric Cancer: A Prospective Comparative Study
Ann Surg Oncol DOI 10.1245/s10434-012-2544-7 ORIGINAL ARTICLE GASTROINTESTINAL ONCOLOGY Guidelines for Extended Lymphadenectomy in Gastric Cancer: A Prospective Comparative Study Oktar Asoglu, MD 1, Tugba
More informationDetermining Resectability and Appropriate Surgery for Esophageal Cancer
Determining Resectability and Appropriate Surgery for Esophageal Cancer Peter Baik, DO, FACOS Thoracic Surgery Cancer Treatment Centers of America 1 Esophageal and Esophagogastric Junction Cancers Siewert
More informationMinimally Invasive Esophagectomy- Valuable. Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006
Minimally Invasive Esophagectomy- Valuable Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006 Overview Esophageal carcinoma What is minimally invasive esophagectomy (MIE)?
More informationCOLON AND RECTAL CANCER
COLON AND RECTAL CANCER Mark Sun, MD Clinical Associate Professor of Surgery University of Minnesota No disclosures Objectives 1) Understand the epidemiology, management, and prognosis of colon and rectal
More informationPatient. Male 76 year old C.C: abdominal pain
Patient Male 76 year old C.C: abdominal pain Bowel stool retention Suspected pulmonary TB at right upper lung Infiltration in right lower lung Pleural thickening at the Right chest Localized dilated small
More informationGreater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy
Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Authors: Dr Gordon Armstrong, Dr Sue Pritchard 1. General Comments 1.1 Cancer reporting: Biopsies
More informationStaging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion
5 th of June 2009 Background Most common gynaecological carcinoma in developed countries Most cases are post-menopausal Increasing incidence in certain age groups Increasing death rates in the USA 5-year
More information